Loch D - Search Results

1

Circulating transforming growth factor-beta in Marfan syndrome.

Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, Loeys B, Huso DL, McDonnell NB, Van Eyk JE, Dietz HC; GenTAC Consortium. Matt P, et al. Among authors: loch d. Circulation. 2009 Aug 11;120(6):526-32. doi: 10.1161/CIRCULATIONAHA.108.841981. Epub 2009 Jul 27. Circulation. 2009. PMID: 19635970 Free PMC article.

2

Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis.

Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, van Erp C, Gerber EE, Parker SJ, Sauls K, Judge DP, Cooke SK, Lindsay ME, Rouf R, Myers L, ap Rhys CM, Kent KC, Norris RA, Huso DL, Dietz HC. Gallo EM, et al. Among authors: loch dc. J Clin Invest. 2014 Jan;124(1):448-60. doi: 10.1172/JCI69666. Epub 2013 Dec 20. J Clin Invest. 2014. PMID: 24355923 Free PMC article.

3

p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice.

Carta L, Smaldone S, Zilberberg L, Loch D, Dietz HC, Rifkin DB, Ramirez F. Carta L, et al. Among authors: loch d. J Biol Chem. 2009 Feb 27;284(9):5630-6. doi: 10.1074/jbc.M806962200. Epub 2008 Dec 24. J Biol Chem. 2009. PMID: 19109253 Free PMC article.

4

Timeline of cardiac dystrophy in 3-18-month-old MDX mice.

Van Erp C, Loch D, Laws N, Trebbin A, Hoey AJ. Van Erp C, et al. Among authors: loch d. Muscle Nerve. 2010 Oct;42(4):504-13. doi: 10.1002/mus.21716. Muscle Nerve. 2010. PMID: 20589894

5

Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.

Loch D, Hoey A, Brown L. Loch D, et al. Clin Exp Hypertens. 2006 Jul;28(5):475-88. doi: 10.1080/10641960600798754. Clin Exp Hypertens. 2006. PMID: 16820344

6

Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase.

Loch D, Hoey A, Morisseau C, Hammock BO, Brown L. Loch D, et al. Cell Biochem Biophys. 2007;47(1):87-98. doi: 10.1385/cbb:47:1:87. Cell Biochem Biophys. 2007. PMID: 17406062 Free PMC article.

7

Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.

Loch D, Chan V, Hoey A, Brown L. Loch D, et al. Basic Clin Pharmacol Toxicol. 2009 Oct;105(4):262-70. doi: 10.1111/j.1742-7843.2009.00440.x. Epub 2009 Jul 2. Basic Clin Pharmacol Toxicol. 2009. PMID: 19583711 Free article.

8

Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.

Loch D, Levick S, Hoey A, Brown L. Loch D, et al. J Cardiovasc Pharmacol. 2006 Mar;47(3):396-404. doi: 10.1097/01.fjc.0000210072.48991.f6. J Cardiovasc Pharmacol. 2006. PMID: 16633082

9

Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats.

Chan V, Fenning A, Levick SP, Loch D, Chunduri P, Iyer A, Teo YL, Hoey A, Wilson K, Burstow D, Brown L. Chan V, et al. Among authors: loch d. J Cardiovasc Pharmacol. 2011 Apr;57(4):469-78. doi: 10.1097/FJC.0b013e3182102c3b. J Cardiovasc Pharmacol. 2011. PMID: 21283019

10

Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats.

Levick S, Loch D, Rolfe B, Reid RC, Fairlie DP, Taylor SM, Brown L. Levick S, et al. Among authors: loch d. J Immunol. 2006 Jun 1;176(11):7000-7. doi: 10.4049/jimmunol.176.11.7000. J Immunol. 2006. PMID: 16709861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters